HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dihydrotetramethylrosamine

structure given in first source

Also Known As:

DHTM Ros

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 3-Ring Heterocyclic Compounds
    - Xanthenes: 65
      - Rhodamines: 466
        dihydrotetramethylrosamine: 2

Experts

1.	Hamada, Masashi: 1 article (09/2008)
2.	Kakigi, Akinobu: 1 article (09/2008)
3.	Nakatani, Hiroaki: 1 article (09/2008)
4.	Okada, Teruhiko: 1 article (09/2008)
5.	Takeda, Setsuko: 1 article (09/2008)
6.	Takeda, Taizo: 1 article (09/2008)
7.	Takumida, Masaya: 1 article (09/2008)
8.	Yamakawa, Kazuhiro: 1 article (09/2008)

Related Diseases

1.	Neoplasms (Cancer) 08/01/1993 - "During ADCC normal neutrophils, but not neutrophils obtained from CGD patients, triggered the oxidation of dihydrorhodamine 123 and dihydrotetramethylrosamine within tumor cells. " 08/01/1993 - "YAC tumor cells were also labeled with dihydrorhodamine 123 or dihydrotetramethylrosamine. "
2.	Ischemia 09/01/2008 - "Edaravone injection from immediately after PA interruption significantly reduced dihydrotetramethylrosamine fluorescence intensity (indicative of ROS) in the facial nerve of the interrupted ear and attenuated the development of ischemia-induced facial palsy. "
3.	Facial Paralysis (Facial Palsy) 09/01/2008 - "Edaravone injection from immediately after PA interruption significantly reduced dihydrotetramethylrosamine fluorescence intensity (indicative of ROS) in the facial nerve of the interrupted ear and attenuated the development of ischemia-induced facial palsy. "

Related Drugs and Biologics

1.	Edaravone
2.	dihydrorhodamine 123